First Seizure in a Patient on Enzyme-Inducing Therapy
A 47-year-old man with a history of a right frontal lobe resection for a low-grade glioma 3 years ago (no tumor recurrence on surveillance MRI 2 months ago) presents after a witnessed generalized tonic-clonic seizure lasting about 90 seconds. He had no prior seizures and has been seizure-free since surgery without anticonvulsants. His medications are levetiracetam (started 6 weeks ago for a new diagnosis of focal epilepsy by an outside neurologist, 500 mg twice daily), carbamazepine 400 mg twice daily for trigeminal neuralgia, and atorvastatin. He reports two episodes of déjà vu with lip smacking over the past month that he did not report. Labs: sodium 137, glucose 96, creatinine 0.9. He asks whether the seizure means his tumor is back and whether he can keep taking his current medications.
1. Interpret the semiology and timing. What is the most likely explanation for the new seizures, and how does the MRI result change your management?
Read the worked answer
The déjà vu with lip smacking is a focal aware/dyscognitive seizure with temporal or frontal semiology; the generalized tonic-clonic event is most consistent with focal-to-bilateral tonic-clonic spread. The presence of a stable postoperative MRI and a remote resected low-grade glioma makes tumor recurrence unlikely as the proximate cause; the more likely contributors are (1) a low but persistent risk of epilepsy after resection (even with gross total resection, cortical scarring/glioneuronal reorganization is epileptogenic) and (2) possibly subtherapeutic or fluctuating levetiracetam levels. The MRI being negative does not exclude epilepsy - it changes the workup toward confirming seizure type and optimizing therapy rather than repeating imaging urgently. The key teaching point: a stable scan does not mean the seizure is not epileptic; the semiology and history are the diagnostic anchors.
2. He is on carbamazepine for trigeminal neuralgia and levetiracetam for seizures. How would you reconcile the two drugs, and what specific interaction concerns apply?
Read the worked answer
Carbamazepine is a potent CYP3A4 inducer and also induces its own metabolism (autoinduction); it will lower levetiracetam exposure only modestly (levetiracetam is renally cleared and not CYP-metabolized, so this is not a major concern), but it can lower atorvastatin levels and, more importantly, carbamazepine can cause hyponatremia (SIADH) and has its own CNS side effects. The more relevant issue is that carbamazepine is a reasonable anticonvulsant for focal epilepsy but is a poor choice in a patient with a structural lesion and potential for drug interactions. A pragmatic reconciliation: continue carbamazepine for trigeminal neuralgia if it is working, but recognize it is also treating his focal epilepsy; if you add or switch, use an agent with clean interactions (levetiracetam, lacosamide, lamotrigine with titration caution, or brivaracetam). Do not abruptly stop carbamazepine - withdrawal can provoke seizures. Check sodium and a CBC/LFTs given carbamazepine's hyponatremia and hepatotoxicity risks.
3. He asks if he can stop levetiracetam because he 'only had one big seizure.' How do you counsel him, and what monitoring plan do you propose?
Read the worked answer
Counsel that he has had at least three seizures (two focal dyscognitive plus one bilateral tonic-clonic), not one, and that a structural lesion with prior resection carries a high recurrence risk; withdrawal now would be unsafe. The decision to treat is supported by the presence of a known epileptogenic lesion and recurrent focal seizures. Plan: continue levetiracetam (consider dose optimization upward if breakthrough focal seizures continue), continue carbamazepine for trigeminal neuralgia unless side effects warrant change, document seizure diary, and reassess in 3 months. Discuss driving restrictions per local law and safety counseling (bathing, heights, water). If seizures persist despite adequate dosing, reconsider whether the semiology suggests a different focus and consider EEG/video-EEG. Emphasize that the goal is not 'one seizure free interval' but sustained control given the lesion.